4/7/2017

Intranasal Mucosal Atomization Device

Reason for the Shortage

- Teleflex Medical had recalled multiple lots of MAD nasal devices due to potential for inaccurate delivery of atomized medications. There have been several reports of the lots producing streams of medication instead of atomized sprays.

Available Products

- LMA MAD Nasal spray, Teleflex Medical, Intranasal device without syringe 25 count, Product MAD300
- LMA MAD Nasal spray, Teleflex Medical, Intranasal device with syringe 25 count, Product MAD100
- LMA MAD Nasal spray, Teleflex Medical, Intranasal device with syringe and vial adapter 25 count, Product MAD140

Estimated Resupply Dates

- Teleflex Medical has LMA MAD Nasal Intranasal Mucosal Atomization Devices available.

Alternative Agents & Management

- Teleflex has indicated that if customers plan to continue using affected lots of LMA MAD intranasal devices, they are advised to test the product prior to use to determine if it is defective. Teleflex has provided instructions to test the device prior to use. http://www.teleflex.com/global/product-areas/MAD_Atomization_Cust_Notif_and_Ack_Form.pdf
- Please contact Teleflex at [email protected] or 866-246-6990 if you plan to continue using affected lots of MAD Nasal intranasal devices.
- There are no other suppliers of intranasal atomizers. The company has recommended the following alternatives to access routes: 1. For MAD Nasal alternatives, intranasal medication can be delivered using a syringe dropper or soaked pledget. If necessary, consider an alternate access route for drug delivery (buccal, IV, IM, PO, PR). 2. For MADomizer alternatives, intranasal medication can be delivered using a syringe dropper or soaked pledget. 3. For MADgic alternatives, a temporary alternative such as lidocaine gargles (viscous lidocaine), HurriCaine spray (benzocaine) can be used in delivering topical anesthetics.

Updated

Updated April 7, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. Created November 3, 2016 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.